Elo Mutual Pension Insurance Co Has $3.24 Million Stock Holdings in Veeva Systems Inc. (NYSE:VEEV)

Elo Mutual Pension Insurance Co lifted its holdings in Veeva Systems Inc. (NYSE:VEEV - Free Report) by 13.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,397 shares of the technology company's stock after acquiring an additional 1,840 shares during the period. Elo Mutual Pension Insurance Co's holdings in Veeva Systems were worth $3,237,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in VEEV. MassMutual Private Wealth & Trust FSB increased its stake in shares of Veeva Systems by 72.5% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 119 shares of the technology company's stock valued at $25,000 after acquiring an additional 50 shares during the period. Centricity Wealth Management LLC purchased a new stake in shares of Veeva Systems during the 4th quarter worth about $25,000. Smithfield Trust Co lifted its stake in shares of Veeva Systems by 145.5% in the 4th quarter. Smithfield Trust Co now owns 135 shares of the technology company's stock valued at $27,000 after purchasing an additional 80 shares during the last quarter. True Wealth Design LLC raised its stake in shares of Veeva Systems by 3,375.0% in the 3rd quarter. True Wealth Design LLC now owns 139 shares of the technology company's stock valued at $29,000 after acquiring an additional 135 shares in the last quarter. Finally, Avion Wealth lifted its holdings in Veeva Systems by 635.0% in the 4th quarter. Avion Wealth now owns 147 shares of the technology company's stock worth $30,000 after purchasing an additional 127 shares during the last quarter. 88.20% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Analysts Set New Price Targets

VEEV has been the topic of several research reports. Robert W. Baird boosted their price target on Veeva Systems from $283.00 to $285.00 and gave the company an "outperform" rating in a research note on Thursday, March 6th. Canaccord Genuity Group boosted their target price on shares of Veeva Systems from $210.00 to $270.00 and gave the stock a "hold" rating in a research note on Friday, December 6th. StockNews.com upgraded Veeva Systems from a "hold" rating to a "buy" rating in a report on Monday, February 17th. The Goldman Sachs Group cut Veeva Systems from a "buy" rating to a "sell" rating and cut their price objective for the company from $261.00 to $200.00 in a report on Thursday, January 23rd. Finally, Truist Financial lifted their price target on Veeva Systems from $210.00 to $217.00 and gave the stock a "hold" rating in a report on Thursday, March 6th. Two analysts have rated the stock with a sell rating, eight have given a hold rating and sixteen have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $256.52.

Veeva Systems Trading Down 1.1 %

Shares of VEEV traded down $2.56 during midday trading on Monday, reaching $231.65. 1,269,125 shares of the company were exchanged, compared to its average volume of 1,038,842. The stock has a 50-day moving average price of $231.62 and a 200-day moving average price of $222.87. The company has a market cap of $37.61 billion, a price-to-earnings ratio of 57.20, a P/E/G ratio of 1.89 and a beta of 0.88. Veeva Systems Inc. has a 1-year low of $170.25 and a 1-year high of $258.93.

About Veeva Systems

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.